PE Ratio
N/A
Wed, 27 Nov 2024 21:17:23 GMT
Summary:
Cartesian Therapeutics price to earnings ratio is not available.RNAC PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC PE Ratio Performance
PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | -3.5% | -3.1% | -11.4% |
1 m1 month | - | -12.5% | - | - |
3 m3 months | - | +26.8% | - | - |
6 m6 months | - | -26.7% | - | - |
ytdytd | - | -12.9% | - | - |
1 y1 year | - | -48.9% | -465.9% | +38.8% |
5 y5 years | - | -62.3% | -15.2% | - |
RNAC PE Ratio High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | ||||
3 m | 3 months | ||||
6 m | 6 months | ||||
1 y | 1 year | ||||
3 y | 3 years | 260.00 | 10.33 | ||
5 y | 5 years | 260.00 | 10.33 | ||
alltime | all time | 260.00 | 10.33 |
Cartesian Therapeutics PE Ratio History
Date | Value |
---|
Date | Value |
---|---|
2022 | 28.25 |
FAQ
- What is the all time high PE ratio for Cartesian Therapeutics?
What is the all time high PE ratio for Cartesian Therapeutics?
Cartesian Therapeutics all-time high price to earnings ratio is 260.00